These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


495 related items for PubMed ID: 50083

  • 21. Immunoglobulin heavy-chain-associated amyloidosis.
    Eulitz M, Weiss DT, Solomon A.
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650
    [Abstract] [Full Text] [Related]

  • 22. Studies on fd fragments of human immunoglobulins. III. Immunogenic properties of gamma chains, myeloma fd gamma, and myeloma fd1 alpha.
    Zegers JM, Ballieux RE, van Loghem E.
    Scand J Immunol; 1975 Sep; 4(2):161-9. PubMed ID: 806961
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A calcium binding IgG myeloma protein.
    Spira G, Silvian I, Tatarsky I, Hazani A.
    Scand J Haematol; 1980 Mar; 24(3):193-8. PubMed ID: 6769147
    [Abstract] [Full Text] [Related]

  • 25. Partial amino acid sequence of an IgA2 human immunoglobulin heavy chain.
    Wolfenstein-Todel C, Frangione B, Franklin EC.
    Biochim Biophys Acta; 1975 Feb 27; 379(2):627-37. PubMed ID: 804325
    [Abstract] [Full Text] [Related]

  • 26. Intrachain disulphide bridges in immunoglobulin G heavy chains. The Fc fragment.
    Frangione B, Milstein C, Franklin EC.
    Biochem J; 1968 Jan 27; 106(1):15-21. PubMed ID: 4889360
    [Abstract] [Full Text] [Related]

  • 27. [Rule of antibody structure. the primary structure of a monoclonal IgG1 immunoglobulin (myeloma protein Nie), I: Purification and characterization of the protein, the L- and H-chains, the cyanogenbromide cleavage products, and the disulfide bridges (author's transl)].
    Dreker L, Schwarz J, Reichel W, Hilschmann N.
    Hoppe Seylers Z Physiol Chem; 1976 Nov 27; 357(11):1515-40. PubMed ID: 1002129
    [Abstract] [Full Text] [Related]

  • 28. Characterization of upFc, a fragment of human immunoglobulin G1 produced by pepsin in urea.
    Parr DM, Hofmann T, Connell GE.
    Biochem J; 1976 Sep 01; 157(3):535-40. PubMed ID: 791267
    [Abstract] [Full Text] [Related]

  • 29. Evidence for the absence of noncovalent bonds in the Fcmu region of IgM.
    Hester RB, Mole JE, Schrohenloher RE.
    J Immunol; 1975 Jan 01; 114(1 Pt 2):486-91. PubMed ID: 804003
    [Abstract] [Full Text] [Related]

  • 30. Enzymatically produced subunits of proteins formed by plasma cells in mice. I. gamma-Globulin and gamma-myeloma proteins.
    FAHEY JL, ASKONAS BA.
    J Exp Med; 1962 Mar 01; 115(3):623-39. PubMed ID: 13891303
    [Abstract] [Full Text] [Related]

  • 31. Properties of the Fd fragment from rabbit immunoglobulin G.
    Huston JS, Björk I, Tanford C.
    Biochemistry; 1972 Nov 07; 11(23):4256-62. PubMed ID: 4628028
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Structural studies on a human IgA1 myeloma protein with a carboxy terminal deletion.
    Grey HM, Despont JP, Abel CA, Penn GM.
    Adv Exp Med Biol; 1974 Nov 07; 45(0):201-10. PubMed ID: 4213399
    [No Abstract] [Full Text] [Related]

  • 37. The amino acid sequence of a human immunoglobulin G3m(g) pFc' fragment.
    Michaelsen TE, Frangione B, Franklin EC.
    J Immunol; 1977 Aug 07; 119(2):558-63. PubMed ID: 407300
    [Abstract] [Full Text] [Related]

  • 38. A new case of gamma heavy chain disease: clinical, immunochemical and structural characterization.
    Carbonara AO, Paolino W, Malavasi F, Levis A, Stramignoni A, de Lange G, van Loghem E, Franklin EC.
    Vox Sang; 1979 Aug 07; 37(2):89-95. PubMed ID: 91266
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Deletion of hinge region of human myeloma IgG1 molecule (protein LEC) associated with nonexpression of G1m (3) and Km (1, 2) allotypes. A possible genetic explanation at the DNA level.
    Rivat C, Schiff C, Rivat L, Ropartz C, Fougereau M.
    Eur J Immunol; 1976 Aug 07; 6(8):545-51. PubMed ID: 61877
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.